In an in vitro approach (Itoshima et al., 2000), esophageal cancer cells were transfected with a plasmid designed to rise ARF expression (exogenous), with the subsequent reduction of endogenous levels of Mdm2 and induced p53 accumulation. The gene discussed is MDM2; the disease is esophageal cancer.